UTHR
United Therapeutics Corporation
Stock
$541.70−29.68 (−5.19%)Close Oct 2, 2026
- Free cash flow, 2025
- $1.0B
- YoY, 2025
- −3.7%
- 5-year CAGR
- +8.4%
- 10-year CAGR
- +12.1%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $1.0B | −3.7% |
| 2024 | $1.1B | +44.5% |
| 2023 | $748M | +12.6% |
| 2022 | $664M | +39.0% |
| 2021 | $477M | −31.4% |
| 2020 | $696M | — |
| 2019 | −$290M | — |
| 2018 | $594M | +53.1% |
| 2017 | $388M | −35.9% |
| 2016 | $606M | +81.9% |
| 2015 | $333M | +8.2% |
| 2014 | $308M | −21.7% |
| 2013 | $393M | +85.8% |
| 2012 | $212M | −1.2% |
| 2011 | $214M | +11.1% |
| 2010 | $193M | +4,362.0% |
| 2009 | $4.3M | — |
| 2008 | −$165M | — |